Other OTC Pharmaceuticals (Pharmacies) - Timor-Leste

  • Timor-Leste
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$2.38m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.02%, resulting in a market volume of US$2.63m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.73 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Timor-Leste has been experiencing significant growth in recent years. Customers in Timor-Leste have shown a strong preference for over-the-counter (OTC) pharmaceutical products, driving the expansion of this market.

Customer preferences:
Customers in Timor-Leste have a growing preference for OTC pharmaceutical products due to their convenience and accessibility. OTC products allow customers to self-medicate for common ailments without the need for a prescription or a visit to a healthcare professional. This convenience is especially important in Timor-Leste, where access to healthcare services can be limited in some areas. Additionally, OTC products are often more affordable than prescription medications, making them a preferred choice for customers with limited financial resources.

Trends in the market:
One key trend in the Other OTC Pharmaceuticals (Pharmacies) market in Timor-Leste is the increasing demand for basic healthcare products such as pain relievers, cough and cold remedies, and vitamins. These products are essential for addressing common health issues and maintaining overall well-being. As the population becomes more health-conscious and aware of the benefits of preventive healthcare, the demand for these OTC products is expected to continue growing. Another trend in the market is the rising popularity of herbal and natural remedies. Customers in Timor-Leste have a long-standing tradition of using traditional medicines derived from plants and herbs. This preference for natural remedies has led to an increased demand for OTC products that incorporate herbal ingredients. Manufacturers and pharmacies have responded to this trend by offering a wider range of herbal and natural products, catering to the specific needs and preferences of the local market.

Local special circumstances:
Timor-Leste is a small country with a developing healthcare system. The limited availability of healthcare facilities and healthcare professionals in some areas has contributed to the reliance on OTC pharmaceutical products. In addition, the country's geography, with its mountainous terrain and remote villages, poses challenges to accessing healthcare services. OTC products provide a convenient and accessible solution for individuals in these areas, allowing them to address their healthcare needs without traveling long distances.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals (Pharmacies) market in Timor-Leste is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and improved living standards. As a result, individuals have more financial resources to allocate towards healthcare expenses, including OTC pharmaceutical products. This growing purchasing power has fueled the demand for OTC products and contributed to the expansion of the market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Timor-Leste is developing due to customer preferences for convenient and accessible healthcare solutions. The increasing demand for basic healthcare products and herbal remedies, coupled with the limited availability of healthcare services in some areas, has driven the growth of this market. Furthermore, underlying macroeconomic factors, such as economic growth and increased disposable income, have contributed to the expansion of the OTC pharmaceutical market in Timor-Leste.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)